ReviewCurrent atherosclerosis reports2022

GLP-1 Agonist to Treat Obesity and Prevent Cardiovascular Disease: What Have We Achieved so Far?

Maurício Reis Pedrosa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.